Showing results (171-180 of 212) with videos related to
Sort By:
Pageof 22
The Journal of Experimental Medicine|July 1, 1990
Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysisS Meri, B P Morgan, M Wing, et al.International Journal of Cancer|June 11, 1997
Expression and function of the complement membrane attack complex inhibitor protectin (CD59) in human prostate cancerG A Jarvis, J Li, J Hakulinen, et al.Nature|April 3, 1997
A second serine protease associated with mannan-binding lectin that activates complementS Thiel, T Vorup-Jensen, C M Stover, et al.British Journal of Cancer|October 29, 2002
Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cellsS Junnikkala, J Hakulinen, H Jarva, et al.Infection and Immunity|August 17, 2002
The yeast Candida albicans binds complement regulators factor H and FHL-1T Meri, A Hartmann, D Lenk, et al.European Journal of Ophthalmology|December 1, 2007
The effect of complement factor H Y402H polymorphism on the outcome of photodynamic therapy in age-related macular degenerationS P Seitsonen, I E Jarvela, S Meri, et al.Scandinavian Journal of Immunology|June 26, 2007
Plasma surfactant protein D levels and the relation to body mass index in a chinese populationX M Zhao, Y P Wu, R Wei, et al.Leukemia & Lymphoma|November 8, 2001
Complement activation in circulation and central nervous system after rituximab (anti-CD20) treatment of B-cell lymphomaA Harjunpää, T Wiklund, J Collan, et al.British Journal of Cancer|February 24, 2005
Ascitic complement system in ovarian cancerL Bjørge, J Hakulinen, O K Vintermyr, et al.Annals of the Rheumatic Diseases|December 1, 1996
Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membraneY T Konttinen, A Ceponis, S Meri, et al.Pageof 22